DNA/RNA

New England Biolabs launches NEBNext Low-bias Small RNA Library Prep Kit

July 23, 2025

New England Biolabs (NEB) announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimize biased representation of small RNA species in sequencing...

Molecular

Precision Medicine to host webinar

LABline

July 11, 2025

DNA/RNA

Thermo Fisher Scientific introduces fast, automated plasmid DNA purification kit

LABline

May 16, 2025

DNA/RNA

Integrated DNA Technologies and Elegen partner to revolutionize long DNA synthesis market

LABline

April 2, 2025

DNA/RNA

Thermo Fisher Scientific introduces MagMAX Sequential DNA/RNA Kit

LABline

Dec. 18, 2024

DNA/RNA

Inherited genetic factors may predict the pattern of X chromosome loss in older women

LABline

June 13, 2024

DNA/RNA

Circulating tumor DNA levels predict treatment outcomes for patients with gastroesophageal cancer treated with a novel immunotherapy combination

LABline

March 21, 2024

Patients with gastroesophageal cancer who have successfully completed the standard treatment of chemoradiotherapy followed by surgery unfortunately often see a resurgence of the...

DNA/RNA

‘Junk DNA’ no more: Johns Hopkins investigators develop method of identifying cancers from repeat elements of genetic code

LABline

March 14, 2024

New method called ARTEMIS uses machine learning to shed light on human genome “dark matter” involved in cancer and other diseases.

DNA/RNA

RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia

LABline

Feb. 7, 2024

Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the diagnosis and treatment of this heterogeneous...

DNA/RNA

Researchers improve blood tests’ ability to detect and monitor cancer

LABline

Jan. 25, 2024

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

DNA/RNA

CHOP and Penn Medicine researchers develop “in vivo” RNA-based gene editing model for blood disorders

LABline

Aug. 1, 2023

In proof-of-concept paper, researchers show that gene editing tools can be delivered via lipid nanoparticles, which would reduce cost and increase access to cutting-edge gene ...

DNA/RNA

QIAGEN expands next-generation sequencing portfolio with QIAseq Normalizer kits

LABline

July 6, 2023

Normalizes various library types over a broad range of concentrations in only 30 minutes.

DNA/RNA

New findings show mitochondrial DNA fragments in blood as important biomarkers for aging and inflammation

LABline

June 23, 2023

High levels of cell free DNA circulating in blood is further linked to chronic inflammation, a well-known risk factor for severe aging symptoms and frailty in older adults.

DNA/RNA

FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)

LABline

June 22, 2023

NDIS approval provides access to federal government funding for accredited public crime laboratories in the U.S. to implement next-generation sequencing (NGS) for routine casework...

DNA/RNA

CHOP researchers reveal complex assembly process involved in DNA virus replication

LABline

April 21, 2023

Study shows viral proteins utilize phase separation to coordinate complex process of replicating viral genomes and then encapsulating that DNA in a viral particle.